Tomorrow gap down

Next Top Glove

Tomorrow gap up opening.

Tomorrow gap up opening to RM 0.78, short term TP 1.5

Company with solid fundamentals

TP tomorrow 0.25

Will bring good ROI in long-term. For short-term traders, next week can TP at RM0.98-RM1.

Looks like GETS, there is a possibility to goreng till RM 1. On Monday, can buy at opening and TP at RM 0.65-0.67 for short-term traders.

Tomorrow buy at opening and TP at RM0.85-0.87.

Resistant breakout, TP 0.8

I want to make a hat-trick of more>100% increase between IPO purchase and selling on first day. I managed to do that with Optimax (136%) and Samaiden (108%). Hopefully, I can end this year with the same in Econframe.

I foresee a gap up in opening tomorrow, TP tomorrow RM 1.90-2.00.

COVID-19 Vaccine Update: China’s Sinovac Vaccine Appears Safe in Late-stage Clinical Trial

Ref: https://www.india.com/news/world/covid-19-vaccine-update-chinas-sinovac-vaccine-appears-safe-in-late-stage-clinical-trial-4178949/

Be careful, Vaccine is almost there.

COVID-19 Vaccine Update: China’s Sinovac Vaccine Appears Safe in Late-stage Clinical Trial

Ref: https://www.india.com/news/world/covid-19-vaccine-update-chinas-sinovac-vaccine-appears-safe-in-late-stage-clinical-trial-4178949/

Be careful, Vaccine is almost there.

COVID-19 Vaccine Update: China’s Sinovac Vaccine Appears Safe in Late-stage Clinical Trial

Ref: https://www.india.com/news/world/covid-19-vaccine-update-chinas-sinovac-vaccine-appears-safe-in-late-stage-clinical-trial-4178949/

TP RM 1 (short term)

COVID-19 Vaccine Update: China’s Sinovac Vaccine Appears Safe in Late-stage Clinical Trial

Ref: https://www.india.com/news/world/covid-19-vaccine-update-chinas-sinovac-vaccine-appears-safe-in-late-stage-clinical-trial-4178949/

COVID-19 Vaccine Update: China’s Sinovac Vaccine Appears Safe in Late-stage Clinical Trial

Ref: https://www.india.com/news/world/covid-19-vaccine-update-chinas-sinovac-vaccine-appears-safe-in-late-stage-clinical-trial-4178949/

COVID-19 Vaccine Update: China’s Sinovac Vaccine Appears Safe in Late-stage Clinical Trial

Ref: https://www.india.com/news/world/covid-19-vaccine-update-chinas-sinovac-vaccine-appears-safe-in-late-stage-clinical-trial-4178949/

COVID-19 Vaccine Update: China’s Sinovac Vaccine Appears Safe in Late-stage Clinical Trial (posted 8 hrs ago)

Ref: https://www.india.com/news/world/covid-19-vaccine-update-chinas-sinovac-vaccine-appears-safe-in-late-stage-clinical-trial-4178949/

TP RM 1 (short-term)

Good news, short term TP 0.8

He looks not so convincing,RUN!

Buy at opening and take profit in the range of RM 0.285 to RM 0.3.

Possible goreng to 0.3, then drop if he cannot become PM.

It could reach value of RM0.85 to RM1.05.

https://klse.i3investor.com/blogs/JawResearch/2020-09-30-story-h1514388769-Samaiden_IPO_Is_Value_Renewable.jsp

TP RM1

Covid-19 vaccine may be ready by year-end, says WHO's Tedros: https://www.theedgemarkets.com/article/covid19-vaccine-may-be-ready-yearend-says-whos-tedros

DPharma TP: RM 4.00

This stock is keep moving upwards, a hidden gem in Bursa.

Mana uncle, aiyayo.

Pure goreng or later got announcement?

Haha.

LOL.

OMG, 0.41!

SELL, SELL, SELL, RUN!

Slow like snail, speechless.

Well-supported at 0.935-0.945, need more volume to push up.

Sorry for the typo: RM 30000-RM 100000/month. My intention is not to show off. But, if some ppl in this forum are using bad words and downgrading other individual's opinion, then I need to proof myself.

Ppl like Nicky and Ivanlau should learn how to argue properly. Hope your parents taught you some manners.

Hey, Nicky. Watch your words. I am not a "tin kosong". I am a business graduate of one of the top 10 universities in the world. As for healthcare counters, I am always into short-term trade. For example: I bought Comfort at RM 3.06 two days ago and I sold at RM 3.3 yesterday. Below are some of my comments:

1. Cases locally and nearby regions is important. The sales of PPE locally carries equal weight as sales of PPE internationally. Besides, high export and transportation tax should be taken into account for sales beyond ASEAN region. Therefore, reduction of Covid-19 locally is definitely an important point to consider.

2. There are many emerging competitors in the market in different countries. So the supply of PPE is also increasing to meet the increasing demands.

3. Increasing Covid-19 cases does not mean that demand for PPE is increasing rapidly. In some countries like UK, US, etc, mild cases are not quarantined at hospital and instead are allowed for home quarantine.

4. If you analyze the recent movement of rubber glove counters in Malaysia, all depends on the news and quarter report. For example, the recent rebound is due to WHO statement of increasing Covid-19 cases and profitable QR of Ruberex. All you need is one bad news to bring the price down.

In conclusion, number of COVID-19 local cases should be considered as a part of investment decision. Rubber glove counters could move in either direction (upside/downside). But, as a trader, I will take profit when it is necessary and will look again for best entry. Therefore, I am not a sochai or tin kosong as mentioned by brainless morons such as Ivanlau and Nicky.

As for healthcare counters, I am always into short-term trade. Below are some of my comments:

1. Cases locally and nearby regions is important. The sales of PPE locally carries equal weight as sales of PPE internationally. Besides, high export and transportation tax should be taken into account for sales beyond ASEAN region. Therefore, reduction of Covid-19 locally is definitely an important point to consider.

2. There are many emerging competitors in the market in different countries. So the supply of PPE is also increasing to meet the increasing demands.

3. Increasing Covid-19 cases does not mean that demand for PPE is increasing rapidly. In some countries like UK, US, etc, mild cases are not quarantined at hospital and instead are allowed for home quarantine.

4. If you analyze the recent movement of rubber glove counters in Malaysia, all depends on the news and quarter report. For example, the recent rebound is due to WHO statement of increasing Covid-19 cases and profitable QR of Ruberex. All you need is one bad news to bring the price down.

In conclusion, number of COVID-19 local cases should be considered as a part of investment decision. Rubber glove counters could move in either direction (upside/downside). But, as a trader, I will take profit when it is necessary and will look again for best entry.

As for healthcare counters, I am always into short-term trade. Below are some of my comments:

1. Cases locally and nearby regions is important. The sales of PPE locally carries equal weight as sales of PPE internationally. Besides, high export and transportation tax should be taken into account for sales beyond ASEAN region. Therefore, reduction of Covid-19 locally is definitely an important point to consider.

2. There are many emerging competitors in the market in different countries. So the supply of PPE is also increasing to meet the increasing demands.

3. Increasing Covid-19 cases does not mean that demand for PPE is increasing rapidly. In some countries like UK, US, etc, mild cases are not quarantined at hospital and instead are allowed for home quarantine.

4. If you analyze the recent movement of rubber glove counters in Malaysia, all depends on the news and quarter report. For example, the recent rebound is due to WHO statement of increasing Covid-19 cases and profitable QR of Ruberex. All you need is one bad news to bring the price down.

In conclusion, number of COVID-19 local cases should be considered as a part of investment decision. Rubber glove counters could move in either direction (upside/downside). But, as a trader, I will take profit when it is necessary and will look again for best entry.

Final call, heading to RM 1.5 before MCO ends as borders will start to open. Panic buy asnticipated from mid-July.

Covid-19: Only one new case, 21 discharged (July 1): https://www.thestar.com.my/news/nation/2020/07/01/covid-19-only-one-new-case-21-discharged-july-1

Suggest to TP tomorrow.

TP 0.9 tomorrow.

Covid-19: Only one new case, 21 discharged (July 1): https://www.thestar.com.my/news/nation/2020/07/01/covid-19-only-one-new-case-21-discharged-july-1

May be rapid decline tomorrow, luckily I took profit yesterday.

Lousy stock.

If downtrend continues tomorrow, it means that the latest rebound is new lower high. The price will drop to lower, low later.

Buy call for today and sell tomorrow on gap-up.

Buy call for today and sell tomorrow on gap-up.

Final sell call. Once RM 1 broken, might head towards its baseline between 0.7-0.8.

Bad QR: QoQ -1,929.01%, YoY - -267.67%

Luckily manage to sell at 0.6 after lunch break. Will come back later.

Scomnet is the next GPacket (which dropped from 1.3 to 0.54 within 1.5 months). The choice is yours.